CMS Writing Part D Rule That Could Be Vehicle For Many Of Trump’s Drug Price Proposals

By John Wilkerson / May 18, 2018 at 6:00 PM
CMS is writing another Part D rule, according to the unified agenda that outlines agency rulemaking plans, and Ross Margulies, an associate at Foley Hoag, expects that many of the president’s proposals to curb drug prices will be included in that rule. The agenda says an economically significantly rule will be proposed in September laying out programmatic and operational changes to prescription drug benefit and Medicare Advantage programs for contract year 2020. Margulies said the upcoming Part D rule is...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.